(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 5. Expression of CHL2 mRNA in soft tissues. (A) Northern blot analyses with
human multiple tissue blots IV (lanes 1-8) and I (lanes 9-16) are shown. Blots
were first probed with a DNA containing the hCHL2 ORF (CHL2), and
then re-probed with human ß-actin (Clontech). Essentially identical
results were achieved with three different blot batches. Lane 1, spleen; lane
2, thymus; lane 3, prostate; lane 4, testis; lane 5, uterus (without
endometrium); lane 6, small intestine; lane 7, colon; lane 8, peripheral blood
leukocytes; lane 9, heart; lane 10, whole brain; lane 11, placenta; lane 12,
lung; lane 13, liver; lane 14, skeletal muscle; lane 15, kidney; lane 16,
pancreas. (B) In situ hybridization for CHL2 in adult mouse tissues,
shown in paired bright-field (left) and dark-field (right) panels. (a) Uterus
(transverse section) showing CHL2 expression primarily in the
myometrium. (b) Colon, showing weak CHL2 expression in serosal cells
a different pattern to that of CHL1
(Nakayama et al., 2001). muc,
submucosa; mus, muscularis; end, endometrium; myo, myometrium.